Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies ; volume:22 ; number:1 ; day:24 ; month:11 ; year:2021 ; pages:1-12 ; date:12.2021
The journal of headache and pain ; 22, Heft 1 (24.11.2021), 1-12, 12.2021
- Urheber
-
Nahas, Stephanie J.
Nägel, Steffen
Cohen, Joshua M.
Ning, Xiaoping
Janka, Lindsay
Campos, Verena Ramirez
Krasenbaum, Lynda J.
Holle-Lee, Dagny
Kudrow, David
Lampl, Christian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-021-01351-2
- URN
-
urn:nbn:de:101:1-2022013119375302015911
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nahas, Stephanie J.
- Nägel, Steffen
- Cohen, Joshua M.
- Ning, Xiaoping
- Janka, Lindsay
- Campos, Verena Ramirez
- Krasenbaum, Lynda J.
- Holle-Lee, Dagny
- Kudrow, David
- Lampl, Christian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Episodic Migraine and Older Adults
Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
Sex and Gender Considerations in Episodic Migraine
Pediatric migraine and episodic syndromes that may be associated with migraine
Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies
Cerebral neurocysticercosis mimicking or comorbid with episodic migraine?
Alterations in pain processing circuitries in episodic migraine
Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
Nonspecific periaqueductal gray lesions on T2WI in episodic migraine
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Episodic Migraine and Older Adults
Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
Sex and Gender Considerations in Episodic Migraine
Pediatric migraine and episodic syndromes that may be associated with migraine
Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies
Cerebral neurocysticercosis mimicking or comorbid with episodic migraine?
Alterations in pain processing circuitries in episodic migraine
Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
Nonspecific periaqueductal gray lesions on T2WI in episodic migraine
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
Episodic Migraine and Older Adults
Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
Sex and Gender Considerations in Episodic Migraine
Pediatric migraine and episodic syndromes that may be associated with migraine
Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies
Cerebral neurocysticercosis mimicking or comorbid with episodic migraine?
Alterations in pain processing circuitries in episodic migraine
Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies